About Maxtar Bio-Genics Private Limited
Data last updated:
Maxtar Bio-Genics Private Limited is a private limited company based in North West, Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 29 July 2003 and has been in existence for over 23 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24239DL2003PTC121514. Its GSTIN is 06AADCM9577C1ZB (Haryana).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹9.1 Lakh. It is led by directors Madan Lal Bansal and Jagdish Chand Bansal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 310 3rd Floor W Mall, Mangalam Palace Sector – 3 Rohini, North West, Delhi, India – 110085.
As per the financials filed for FY 2025, the company reported a revenue of ₹43.22 Lakh, a decline of 12% compared to the previous year. For the same year it recorded a net profit of ₹29.4 Lakh (net margin 68%) and EBITDA of ₹41.41 Lakh (EBITDA margin 95.8%). Revenue has declined at a compounded annual rate (CAGR) of 57% over three years and 36% over five years.
As per MCA filings, the company has open charges of ₹15 Lakh on record. Court records list 2 cases involving the company, including 1 filed by the company and 1 filed against it.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website maxtarbiogenics.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered Address310 3rd Floor W Mall, Mangalam Palace Sector – 3 Rohini, North West, Delhi, India – 110085
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Maxtar Bio-Genics Private Limited
The main business activity of Maxtar Bio-Genics is real estate. In detail, this covers real estate activities with own or leased property.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| L | Real Estate | L1 | Real estate activities with own or leased property | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Auditor Details of Maxtar Bio-Genics Private Limited
Maxtar Bio-Genics Private Limited is audited by AGGARWAL DHEERAJ & ASSOCIATES for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| AGGARWAL DHEERAJ & ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Maxtar Bio-Genics Private Limited
Maxtar Bio-Genics has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Madan Lal Bansal | Director | 14 Jan 2009 | 17 Years 8 Months | Current |
| Jagdish Chand Bansal | Director | 29 Jul 2003 | 23 Years 2 Months | Current |
Financials of Maxtar Bio-Genics Private Limited FY 2025 filings available
Maxtar Bio-Genics Private Limited reported revenue of ₹43.22 Lakh (down 12% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Maxtar Bio-Genics Private Limited
Revenue has declined at a compounded annual rate (CAGR) of 36% over five years, including a 12% fall in the latest year. EBITDA rose 49% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Maxtar Bio-Genics Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹41.41 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹29.4 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Maxtar Bio-Genics Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 95.8% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 68% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Maxtar Bio-Genics are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Maxtar Bio-Genics Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Maxtar Bio-Genics Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 09 Jul 2021 | Hdfc Bank Limited | ₹15 Lakh | Open |
Total charge records: 1 View all charges
Employees and EPFO Compliance at Maxtar Bio-Genics Private Limited
Employment history and EPFO contributions of people linked to Maxtar Bio-Genics.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Maxtar Bio-Genics Private Limited
Maxtar Bio-Genics has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 06AADCM9577C1ZB | Haryana | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Legal Cases of Maxtar Bio-Genics Private Limited
Maxtar Bio-Genics Private Limited has 2 court cases on record: 1 filed by Maxtar Bio-Genics, 1 filed against it. All cases are disposed. Status as checked between 21 Sep 2026 and 01 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 1 | 0 | 0 |
| District courts | 1 | 1 | 0 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court of Punjab and Haryana | Writ petition | Filed by the company against State of Haryana | Disposed |
| District court, North, Delhi | Civil suit | Filed against the company by State | Disposed |
Full case history
All 2 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit Ratings, Litigation & Regulatory Alerts for Maxtar Bio-Genics Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Maxtar Bio-Genics Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Maxtar Bio-Genics Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Maxtar Bio-Genics Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Maxtar Bio-Genics Private Limited
Frequently Asked Questions about Maxtar Bio-Genics Private Limited
Maxtar Bio-Genics is an active private limited company based in North West, Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 29 July 2003 (23+ years old) and is registered under CIN U24239DL2003PTC121514.
Maxtar Bio-Genics reported revenue of ₹43.22 Lakh for FY 2025 (down 12% YoY).
Maxtar Bio-Genics has 2 current directors:
- Madan Lal Bansal - Director
- Jagdish Chand Bansal - Director
Maxtar Bio-Genics reported a net profit of ₹29.4 Lakh (net margin 68%) and EBITDA of ₹41.41 Lakh (EBITDA margin 95.8%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Maxtar Bio-Genics is -57% over three years and -36% over five years. In the latest year (FY 2025) revenue fell 12%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Maxtar Bio-Genics is 06AADCM9577C1ZB, registered in Haryana.
The CIN (Corporate Identification Number) of Maxtar Bio-Genics is U24239DL2003PTC121514. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Maxtar Bio-Genics has 2 court cases on record: 1 filed by the company and 1 filed against it. Most are in the high courts.
Maxtar Bio-Genics was incorporated on 29 July 2003, making it 23+ years old. It is registered with the Registrar of Companies, Delhi.